If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for Subscription - Update

4 Aug 2021 15:30

RNS Number : 6032H
Amati AIM VCT PLC
04 August 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Amati AIM VCT plc

4 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription - Update

The Board of Amati AIM VCT plc (the "Company") announced on 28 July 2021 that the Company had published a prospectus (the "Prospectus") in connection with proposals to raise up to £40 million (with an over-allotment facility to raise up to a further £25 million), by way of an offer for subscription of new ordinary shares (the "Offer") (the "New Shares").

The Board has been advised that, on the basis of applications received, the Company has successfully raised £40 million under the Offer. The Board does not intend to utilise the over-allotment facility at the current time, but the Investment Manager is closely monitoring potential investment opportunities and, if it is felt appropriate, the Company will seek to raise further funds under the over-allotment facility prior to the Offer closing.

The first allotment of New Shares is expected to be on or around 9 August 2021. Dealings in the New Shares issued under this allotment are expected to become effective on 23 August 2021. The Company is no longer accepting applications in relation to the Offer. Investors whose applications are received after the Company raised £40 million will have their subscription monies returned in accordance with the terms and conditions of the Offer. If the over-allotment facility is to be utilised, the Company will make a further RNS announcement detailing the application process.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUBPRUPGGCC
Date   Source Headline
8th Oct 20213:49 pmRNSNet Asset Value(s)
6th Oct 20219:38 amRNSTransaction in Own Shares
4th Oct 20216:06 pmRNSHalf-year Report
1st Oct 20216:23 pmRNSNet Asset Value(s)
1st Oct 20218:34 amRNSTotal Voting Rights
27th Sep 20218:57 amRNSNet Asset Value(s)
20th Sep 20218:53 amRNSNet Asset Value(s)
15th Sep 20218:48 amRNSTransaction in Own Shares
13th Sep 20218:46 amRNSTransaction in Own Shares
10th Sep 20213:51 pmRNSNet Asset Value(s)
2nd Sep 20218:54 amRNSNet Asset Value(s)
2nd Sep 20218:27 amRNSTotal Voting Rights
31st Aug 202112:03 pmRNSNet Asset Value(s)
25th Aug 20219:53 amRNSIssue of Equity
23rd Aug 20218:46 amRNSNet Asset Value(s)
16th Aug 20218:44 amRNSNet Asset Value(s)
13th Aug 20211:13 pmRNSTransaction in Own Shares
13th Aug 20219:01 amRNSDirector/PDMR Shareholding
11th Aug 20216:24 pmRNSDirector/PDMR Shareholding
10th Aug 202112:14 pmRNSIssue of Equity
9th Aug 20218:36 amRNSNet Asset Value(s)
4th Aug 20213:30 pmRNSOffer for Subscription - Update
3rd Aug 202112:03 pmRNSNet Asset Value(s)
2nd Aug 20218:56 amRNSTotal Voting Rights
28th Jul 20215:14 pmRNSOffer for subscription and Issue of Prospectus
26th Jul 202110:21 amRNSDirector/PDMR Shareholding
26th Jul 202110:17 amRNSIssue of Equity - DRIS
26th Jul 20218:23 amRNSNet Asset Value(s)
19th Jul 20211:48 pmRNSTransaction in Own Shares
19th Jul 202111:42 amRNSNet Asset Value(s)
16th Jul 202112:25 pmRNSTransaction in Own Shares
12th Jul 20218:38 amRNSNet Asset Value(s)
2nd Jul 202110:35 amRNSNet Asset Value(s)
1st Jul 20218:56 amRNSTotal Voting Rights
25th Jun 20215:37 pmRNSNet Asset Value(s)
22nd Jun 20215:22 pmRNSUpdate on Offer for Subscription
22nd Jun 20219:10 amRNSTransaction in Own Shares
21st Jun 202111:54 amRNSTransaction in Own Shares
18th Jun 20215:27 pmRNSNet Asset Value(s)
14th Jun 202110:02 amRNSNet Asset Value(s)
14th Jun 20219:43 amRNSTransaction in Own Shares
10th Jun 20217:00 amRNSDirectorate Change
10th Jun 20217:00 amRNSResult of AGM
7th Jun 20218:42 amRNSNet Asset Value(s)
2nd Jun 20219:09 amRNSNet Asset Value(s)
1st Jun 20211:11 pmRNSTotal Voting Rights
27th May 20211:15 pmRNSDirectorate Change
21st May 20215:35 pmRNSNet Asset Value(s)
17th May 20219:03 amRNSNet Asset Value(s)
12th May 202111:56 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.